Bone Biologics Corp (BBLG): Price and Financial Metrics

Bone Biologics Corp (BBLG): $1.26

0.06 (-4.55%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

F

BBLG Price/Volume Stats

Current price $1.26 52-week high $10.56
Prev. close $1.32 52-week low $0.80
Day low $1.25 Volume 22,100
Day high $1.32 Avg. volume 1,505,719
50-day MA $1.65 Dividend yield N/A
200-day MA $1.81 Market Cap 3.10M

BBLG Stock Price Chart Interactive Chart >


Bone Biologics Corp (BBLG) Company Bio


Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.


BBLG Latest News Stream


Event/Time News Detail
Loading, please wait...

BBLG Latest Social Stream


Loading social stream, please wait...

View Full BBLG Social Stream

BBLG Price Returns

1-mo -30.39%
3-mo -20.75%
6-mo -16.00%
1-year -67.59%
3-year -99.87%
5-year N/A
YTD -72.12%
2023 -91.02%
2022 -94.04%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!